Citius Pharmaceuticals, Inc. (CTXR)

NASDAQ: CTXR · Real-Time Price · USD

0.7706

-0.0418 (-5.15%)

At close: Mar 20, 2026, 4:00 PM EDT

0.7860

+0.0154 (2.00%)

After-hours: Mar 20, 2026, 6:37 PM EDT

Citius Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Selling, General & Admin	30.71	30.09	21.91	15.66	11.29	8.9
Research & Development	10.43	11.91	14.82	17.66	12.24	8.81
Total Operating Expenses	41.14	42	36.73	33.32	23.53	17.71
Operating Income	-41.14	-42	-36.73	-33.32	-23.53	-17.71
Interest Income	-0.58	0.76	1.18	0.25	0.26	0.07
Interest Expense	-	-	-	-	-0.01	-0.02
Other Non-Operating Income (Expense)	-	2.39	3.59	-	0.23	0.11
Total Non-Operating Income (Expense)	-0.58	3.15	4.77	0.25	0.48	0.16
Pretax Income	-41.14	-38.85	-31.97	-33.06	-23.05	-17.55
Provision for Income Taxes	0.94	0.58	0.58	0.58	-	-
Net Income	-40.99	-40.19	-33.69	-33.64	-24.51	-17.55
Minority Interest in Earnings	-1.81	-0.29	-	-	-	-
Net Income Attributable to Preferred Dividends	-	-1.05	-1.15	-	1.45	-
Net Income to Common	-40.99	-40.19	-33.69	-33.64	-24.51	-17.55
Shares Outstanding (Basic)	9	7	6	6	4	2
Shares Outstanding (Diluted)	9	7	6	6	4	2
Shares Change (YoY)	31.80%	11.16%	3.57%	34.52%	177.28%	94.25%
EPS (Basic)	-4.96	-5.97	-5.57	-5.75	-5.75	-11.25
EPS (Diluted)	-4.96	-5.97	-5.57	-5.75	-5.75	-11.25
Free Cash Flow	-20.58	-28.2	-29.06	-28.36	-24.26	-16.93
Free Cash Flow Per Share	-2.40	-4.19	-4.80	-4.85	-5.58	-10.81
EBITDA	-40.93	-41.79	-36.54	-33.14	-23.37	-17.56
EBIT	-41.14	-42	-36.73	-33.32	-23.53	-17.71
Effective Tax Rate	-2.28%	-1.48%	-1.80%	-1.74%	0.00%	0.00%

Updated Dec 23, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q